Replik auf den „Letter to Editor: Series of articles by T. Bertsch and G. Erbacher culminating in Lipoedema – myths and facts, Part 5: European Best Practice of Lipoedema – Summary of the European Lipoedema Forum Consensus“

Erneut ein Leserbrief aus den USA und erneut einer, der von einer US-amerikanischen Patientenselbsthilfegruppe getragen wird, diesmal DER ANDEREN in unserer letzten Replik [1] bereits erwähnten Selbsthilfegruppe: „Lipedema Simplified“ [2] bzw. dem damit aufs Engste verwobene „The Lipedema Project“ [3]. Es lohnt sich, einen Blick auf diese sehr ansprechend gestaltete Website zu werfen, um eine Ahnung davon zu haben, welches merkantile, aber auch professionelle Know-how hinter dieser – so die Autoren des Leserbriefs – „Non-Profit“- Organisation steckt. Die Mitgliederzahl dieser Organisation wird mit 21 500 beziffert, nachprüfbar war dies für uns nicht, eine entsprechende Referenz wurde nicht genannt.

Publication History

Article published online:
17 February 2021

• Literatur

• 1 Bertsch T, Erbacher G. Response to the Letter to the Editor regarding Lipoedema – myths and facts, Part 1 and Part 5. European Best Practice of Lipoedema – Summary of the European Lipoedema Forum consensus. Phlebologie 2020; 49: 31-49
• 2 Abrufbar unter: https://lipedema-simplified.org
• 3 Abrufbar unter: https://lipedemaproject.org
• 4 Abrufbar unter: https://lipedema-simplified.org/masterclass2020/
• 5 Abrufbar unter: https://lymfsverige.se/omoss.html
• 6 Bertsch T, Erbacher G. Lipedema – myths and facts. Part 1. Phlebologie 2018; 47: 84-92
• 7 Bertsch T, Erbacher G. Lipedema – myths and facts. Part 2. Phlebologie 2018; 47: 120-126
• 8 Bertsch T, Erbacher G. Lipedema – myths and facts. Part 3. Phlebologie 2018; 47: 188-197
• 9 Bertsch T, Torio-Padron N, Erbacher G. Lipedema – myths and facts. Part 4. Phlebologie 2019; 48: 47-56
• 10 Bertsch T, Erbacher G, Corda D. et al Lipoedema: myths and facts, part 5. European best practice of lipoedema – summary of the European Lipoedema Forum consensus. 2020 https://doi.org/10.1055/a-1012-7670
• 11 Abrufbar unter: http://www.lymfologi.se/lipodem/
• 12 Bertsch T, Martin KP. Obesity prevalence among lipoedema patients in a lymphological outpatient clinic with statutory health insurance in 2015 (unpublished data).
• 13 Bosman J. Lipoedema: poor knowledge, neglect or disinterest?. J Lym- phoedema 2011; 6 (02) 109-111
• 14 Child AH, Gordon KD, Sharpe P. Lipedema: an inherited condition. Am J Med Genet A 2010; 152A [phone] . https://doi.org/10.1002/ ajmg.a.33313
• 15 Herbst KL, Mirkovskaya L, Bharhagava A. et al Lipedema fat and signs and symptoms of illness, increase with advancing stage. Arch Med 2015; 7: 10
• 16 Dudeck JE, Białaszek W, Ostaszewski P. et al Depression and appearance related distress in functioning with lipedema. Psychol Health Med 2018; 23 (07) 846-853 . https://doi.org/10.1080/13548506.2018.1459750
• 17 Bertsch T, Erbacher G, Elwell R. et al Lipoedema: a paradigm shift and consensus. J Wound Care 2020; 29 (Suppl. 02) S1-S52
• 18 Erbacher G, Bertsch T. Lipoedema and pain: what is the role of the psyche? Results of a pilot study with 150 lipoedema patients. Phlebologie 2020; 49 (05) 305-316 . https://doi.org/10.1055/a-1238-6657
• 19 Linsmayer D, Neidlinger PK, Braus DF. Rheuma und Psyche – Eine Kurzübersicht. Orthopäde 2019; 48 (11) 957-962 . doi:10.1007/s00132-019-03812-8
• 20 Baerwald C, Manger B, Hueber A. Depression als Komorbidität bei rheumatoider Arthritis. Z Rheumatol 2019; 78: 243-248 . https://doi.org/10.1007/s00393-018-0568-5
• 21 Hofmann P, Hemberger S, Lunzer R. et al Psychische Aspekte der rheumatoiden Arthritis Wie ansprechen? Wie behandeln? Zusammenfassung des Expertenmeetings „Rheuma trifft Psyche“ am 05.11.2015. Abrufbar unter: ttps://www.pfizermed.at/sites/default/files/rheuma_trifft_psyche.pd
• 22 Bischoff N, Morina N, Egloff N. Chronischer Schmerz bei Traumatisierung. Komplexität und Herausforderung bei Diagnostik und Therapie. PiD – Psychotherapie im Dialog 2016; 17 (04) 69-72 . doi:10.1055/s-0042-116706
• 23 Viana MC. et al Prior mental disorders and subsequent onset of chronic back or neck pain: findings from 19 countries. J Pain 2018; 19 (01) 99-110 . doi:10.1016/j.jpain.2017.08.011
• 24 Tegethoff M, Belardi A, Stalujanis E. Comorbidity of Mental Disorders and Chronic Pain: Chronology of Onset in Adolescents of a National Representative Cohort. The Journal of Pain 2015; 16 (10) 1054-1064 . doi:https://doi.org/10.1016/j.jpain.2015.06.009
• 25 Hooten WM. Chronic Pain and Mental Health Disorders. 2016 Mayo Foundation for Medical Education and Research, Mayo Clin Proc 2016; 91 (07) 955-970
• 26 Abrufbar unter: https://www.mayoclinicproceedings.org/article/S0025-6196(16)30182-3/pdf
• 27 Crescenzi R, Marton A, Donahue PMC. et al Tissue Sodium Content is Elevated in the Skin and Subcutaneous Adipose Tissue in Women with Lipedema. Obesity 2017; 26: 310-317 . doi:org/10.1002/oby.22090
• 28 Ma W, Gil HJ, Escobedo N. et al Platelet factor 4 is a biomarker for lymphatic-promoted disorders. JCI Insight 2020; 5: 13e135109 . doi:10.1172/jci.insight.135109
• 29 Bertsch T. Obesity-related lymphoedema – underestimated and undertreated. Phlebologie 2018; 47 (02) 75-83
• 30 Lipedema simplified, webinar: Abrufbar unter. https://lipedema-simplified.org/webinar2020-pf4/ ; hier Minute 14:37-14:47
• 31 Lohrmann C, Foeldi E, Langer M. MR imaging of the lymphatic system in patients with lipedema and lipo-lymphedema. Microvasc Res 2009; 77: 335-339 . doi:org/10.1016/j.mvr.2009.01.005
• 32 Forner-Cordero I, Oliván-Sasot P, Ruiz-Llorca C. et al Hallazgos linfogammagráficos en pacientes con lipedema. Rev Esp Med Nucl Imagen Mol 2018; 37: 341-348 . doi:org/10.1016/j.remnie.2018.10.013
• 33 Shang T, Liang J, Kapron C. et al Pathophysiology of aged lymphatic vessels. Aging 2019; 11 (16) 6602-6613
• 34 Gould DJ, El-Sabawi B, Goel P. et al Uncovering Lymphatic Transport Abnormalities in Patients with Primary Lipedema. J Reconstr Microsurg 2019; 36: 136-141 . doi:10.1055/s-0039-1697904
• 35 Abrufbar unter: https://www.pschyrembel.de/Ödem/K0FKR
• 36 Hirsch T, Schleinitz J, Faerber G. et al Is the differential diagnosis of lipoedema by means of high-resolution ultrasonography possible?. Phlebologie 2018; 47 (04) 182-187
• 37 Cellina M, Gibelli D, Soresina M. et al Non-contrast MR Lymphography of lipedema. Magent Resonance Imaging 2020; 71: 115-124
• 38 Reich-Schupke S, Altmeyer P, Stücker M. Thick legs – not always lipedema. J Dtsch Dermatol Ges 2013; 11 (03) 225-233
• 39 Lipedema – Guidelines in the Netherlands 2014. Abrufbar unter https://www.gdlymph.eu/assets/pdf/Dutch-lipoedema-guideline-2014.pdf
• 40 Stunkard A. The Results of Treatment for Obesity. A Review of the Literature and Report of a Series. AMA Arch Intern Med 1959; 103 (01) 79-85
• 41 Bennett W, Gurin J. The Dieter’s Dilemma: Why Diets Are Obsolete–the New Setpoint Theory of Weight Control. New York: Basic Books; 1982
• 42 Cogan J, Rothblum E. Outcomes of weight-loss Programs. Genetic, Social and General Psychology Monographs 1993; 118: 4
• 43 Perri MG, Nezu AM, Patti ET. et al. Success and failure in the treatment of obesity: Where do we go from here?. Medicine, Exercise, Nutrition and Health 1995; 4: 255-272
• 44 Hensrud DD, Weinsier RL. A prospective study of weight maintenance in obese subjects reduced to normal body weight without weight-loss training. American clinical Nutrtion 1994; 60 (05) 688-694
• 45 Mann T, Tomiyama AJ, Westling E. Medicare’s search for effective obesity treatments: diets are not the answer. Am Psychol 2007; 62 (03) 220-233
• 46 Nordmann A, Bucher H. Effects of low carb vs low fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. Arch Internal Med 2006; 166 (08) 285-293
• 47 Fildes A, Charlton J. Probability of an obese person attaining normal body weight. American Journal of Public Health 2015; 105 (09) e54-e59
• 48 Pietiläinen KH, Saarni SE, Kaprio J. Does Dieting Make You Fat?. International J of Obesity 2012; 36 (03) 456-464
• 49 Bosy-Westhpal A. Effect of weight loss and regain on adipose tissue distribution, composition of lean mass and resting energy expenditure in young overweight and obese adults. Int J Obes (Lond) 2013; 37 (10) 1371-1377
• 50 Buchwald H, Estok R, Fahrbach K. et al Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009; 122: 248-256
• 51 Wittgrove AC, Clark GW. Laparoscopic Gastric Bypass, Roux-en-Y – 500 Patients: Technique and Results, with 3–60 months follow-up. Obes Surg 2000; 10: 233
• 52 Sugerman HJ, Londrey GL, Kellum JM. et al. Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg 2003; 237: 751-756
• 53 Rasheid S, Banasiak M, Lipska A. et al. Bypass is an Effective Treatment for Obstructive Sleep Apnea in Patients with Clinically Significant Obesity. Obes Surg 2003; 13: 5
• 54 Courcoulas AP, Yanovski S, Arterburn DE. et al. Long-term Outcomes of Bariatric Surgery: A National Institutes of Health Symposium. JAMA Surg 2014; 149 (12) 1323-1329
• 55 Arterburn DE, Olsen M, Maciejewski M. et al. Association Between Bariatric Surgery and Long-term Survival. JAMA 2015; 313 (01) 62-70
• 56 Sjöström L, Nabro K, Sjöström D. et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007; 357: 741-752
• 57 Adams TD, Gress R, Hunt S. et al. Long-term mortality after gastric bypass surgery. N Engl J Med 2007; 357: 753-761
• 58 Shubeck S, Dimmick J, Telem D. Long-term Outcomes Following Bariatric Surgery. JAMA 2018; 319 (03) 302-303
• 59 Fink JM, Schreiner L, Bertsch T. Leg volume in patients with lipedema following bariatric surgery. Visc Med 2020;